% alzhub.org library filter
% Source: https://alzhub.org/research?author=Mer%C3%A7%C3%A9+Boada&institution=I4210097985
% 3 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{oomens2025-39841474,
  author  = {Oomens, Julie Elisabeth and van Gils, Veerle and Vos, Stephanie J. B. and Freeze, Whitney M. and Maserejian, Nancy Nairi and Curiale, Gioacchino G. and Gillis, Cai and Boada, Merçé and others},
  title   = {{Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study}},
  journal = {JAMA Network Open},
  year    = {2025},
  doi     = {10.1001/jamanetworkopen.2024.55571},
  pmid    = {39841474},
  url     = {https://doi.org/10.1001/jamanetworkopen.2024.55571}
}

@article{frederiksen2025-40413561,
  author  = {Frederiksen, Kristian Steen and Boada, Merçé and Dubois, Bruno and Engelborghs, Sebastiaan and Frisoni, Giovanni Battista and Georges, Jean and Hort, Jakub and Jönsson, Linus and others},
  title   = {{Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADC}},
  journal = {Alzheimer s Research \& Therapy},
  year    = {2025},
  doi     = {10.1186/s13195-025-01766-y},
  pmid    = {40413561},
  url     = {https://doi.org/10.1186/s13195-025-01766-y}
}

@article{jessen2025-40640062,
  author  = {Jessen, Frank and Arbizu, Javier and Boada, Merçé and Balasa, Mircea and Bennys, Karim and Boban, Marina and Bürger, Katharina and Chincarini, A. and others},
  title   = {{Comment by European Alzheimer’s Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer’ s disease}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100259},
  pmid    = {40640062},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100259}
}